EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Medication-induced central sleep apnea: a unifying concept

Shahrokh Javaheri, Winfried J Randerath, M Safwan Badr, Sogol Javaheri

SLEEP · 14.08.2024 · 47 (8)

DOI: 10.1093/sleep/zsae038 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift SLEEP, online erschienen am 09.02.2024. Verfasst von Shahrokh Javaheri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Sleep Medicine, Bethesda North Hospital, Cincinnati, OH, USA. Hauptthemen laut MEDLINE: Sleep Apnea, Central. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 111 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Medication-induced central sleep apnea (CSA) is one of the eight categories of causes of CSA but in the absence of awareness and careful history may be misclassified as primary CSA. While opioids are a well-known cause of respiratory depression and CSA, non-opioid medications including sodium oxybate, baclofen, valproic acid, gabapentin, and ticagrelor are less well-recognized. Opioids-induced respiratory depression and CSA are mediated primarily by µ-opioid receptors, which are abundant in the pontomedullary centers involved in breathing. The non-opioid medications, sodium oxybate, baclofen, valproic acid, and gabapentin, act upon brainstem gamma-aminobutyric acid (GABA) receptors, which co-colonize with µ-opioid receptors and mediate CSA. The pattern of ataxic breathing associated with these medications is like that induced by opioids on polysomnogram. Finally, ticagrelor also causes periodic breathing and CSA by increasing central chemosensitivity and ventilatory response to carbon dioxide. Given the potential consequences of CSA and the association between some of these medications with mortality, it is critical to recognize these adverse drug reactions, particularly because discontinuation of the offending agents has been shown to eliminate CSA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Apnea, CentralHumansAnalgesics, OpioidTicagrelorSodium OxybateBaclofenValproic AcidAdenosineGabapentinPolysomnography

Stichwörter der Autor:innen

baclofencentral sleep apneagabapentinopioidsrespiratory controlticagrelorvalproic acid

Substanzen

Analgesics, OpioidTicagrelorSodium OxybateBaclofenValproic AcidAdenosineGabapentin

Autor:innen und Institutionen

  • Division of Pulmonary and Sleep Medicine, Bethesda North Hospital, Cincinnati, OH, USA.
  • Adjunct Professor of Medicine, Division of Cardiology, The Ohio State University, Columbus, Ohio, USA.
  • Emeritus Professor of Medicine, Division of Pulmonary and Sleep Medicine, University of Cincinnati, Cincinnati, OH, USA.
  • Professor and Head Physician, Institute of Pneumology, University of Cologne, Bethanien Hospital, Solingen, Germany.
  • Professor and Chair, Department of Internal Medicine, Wayne State University School of Medicine Detroit, Staff Physician, John D. Dingell VA Medical Center, MI, USA.
  • Assistant Professor of Sleep Medicine, Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Zitieren

APA

Javaheri, S., Randerath, W. J., Safwan Badr, M., & Javaheri, S. (2024). Medication-induced central sleep apnea: a unifying concept. SLEEP, 47(8). https://doi.org/10.1093/sleep/zsae038

Vancouver

Javaheri S, Randerath WJ, Safwan Badr M, Javaheri S. Medication-induced central sleep apnea: a unifying concept. SLEEP. 2024;47(8). doi:10.1093/sleep/zsae038

BibTeX
@article{Javaheri2024,
  author = {Javaheri, Shahrokh and Randerath, Winfried J and Safwan Badr, M and Javaheri, Sogol},
  title = {Medication-induced central sleep apnea: a unifying concept},
  journal = {SLEEP},
  year = {2024},
  volume = {47},
  number = {8},
  doi = {10.1093/sleep/zsae038}
}
Kostenlos starten →